Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology

Vueway

MRI of the Liver: Choosing the right Contrast Agent During this Webinar we will discuss with some Experts how they manage the choice of contrast agent/s in liver MRI.

MRI of malignant Liver Lesions: Which MR Contrast Agent? Which diagnostic criteria? It will address the choice of MR contrast agent in the suspicion or follow-up of focal hepatic malignant lesions most frequently observed in the clinical practice.

Diagnostic challenges of benign/incidental lesions at Liver MRI and CEUS It will address the topic of MR imaging of benign lesions.

Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Bracco Imaging has won the Gold Medal from EcoVadis The company is now proudly sporting the EcoVadis gold medal for what it has managed to achieve in four key areas: environment, ethics, labour and human rights, sustainable procurement.

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

EuSoMII/Bracco AI Contest Pisa, Italy, on the 13th and 14th of October 2023, the European Society of Medical Imaging Informatics hosted its annual gathering. Aptly titled "AI: Connecting the dots," this event brought together minds from different corners of the medical and radiology world to explore the boundless possibilities of Artificial Intelligence.